Platinum Industries Ltd

Platinum Industries Q3 FY2025 Results 📊 | New Pharma Subsidiary & Financial Highlights

• Consolidated Q3 FY2025 revenue: ₹1,079.10 million

• Nine-month revenue (ended Dec 31, 2025): ₹3,304.29 million

• Q3 net profit: ₹123.28 million

• Nine-month net profit: ₹363.87 million

• New subsidiary 'Rivadu Lifesciences' incorporated with initial capital up to ₹25,00,000

• Rivadu Lifesciences will focus on pharmaceuticals and lifesciences business expansion

• Exceptional item loss of ₹5.17 million related to fire incident